Xiaoxiang Zhu Selected Research

Z-1-117

11/2002

p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoxiang Zhu Research Topics

Disease

2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2004 - 11/2002
2	Erythema Nodosum 01/2004 - 11/2003
2	Alzheimer Disease (Alzheimer's Disease) 01/2004 - 11/2002
1	Hypoxia (Hypoxemia) 08/2014
1	Hyperhomocysteinemia 10/2004
1	Glioblastoma (Glioblastoma Multiforme) 09/2004
1	Rheumatoid Arthritis 01/2004
1	Neoplasms (Cancer) 11/2003
1	Communicable Diseases (Infectious Diseases) 11/2003
1	Multiple Myeloma 11/2003
1	Wounds and Injuries (Trauma) 01/2003
1	Stroke (Strokes) 11/2002
1	Parkinson Disease (Parkinson's Disease) 11/2002
1	Neuroblastoma 09/2002

Drug/Important Bio-Agent (IBA)

2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004 - 11/2003
2	Thalidomide (Thalomid)FDA Link 01/2004 - 11/2003
2	pifithrinIBA 01/2003 - 11/2002
1	PC6 extract (PC6)IBA 08/2014
1	CarbonIBA 10/2004
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 10/2004
1	UracilIBA 10/2004
1	Messenger RNA (mRNA)IBA 10/2004
1	Protein Isoforms (Isoforms)IBA 09/2004
1	CytokinesIBA 01/2004
1	Etoposide (VP 16)FDA LinkGeneric 01/2003
1	DNA (Deoxyribonucleic Acid)IBA 11/2002
1	Neuroprotective AgentsIBA 11/2002
1	CamptothecinIBA 11/2002
1	Z-1-117IBA 11/2002
1	Tumor Suppressor Protein p53IBA 11/2002
1	Tumor Protein p73IBA 09/2002
1	RNA (Ribonucleic Acid)IBA 09/2002